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Abstract 
Cystic hygroma (CH) is a lymphatic malfor-
mation occurring different parts of fetal body,
typically in the region of the fetal neck and
axillary, abdominal wall, mediastinal, inguinal
and retroperitoneal areas. CH has been associ-
ated  with  fetal  aneuploidy,  hydrops  fetalis,
structural  malformations  and  intrauterine
fetal death.
A 24-year-old gravida 1, para 1 was admit-
ted to our hospital at 28 weeks of gestation.
Ultrasonographic examination determined 28
weeks of gestation, singleton, alive fetus who
had  a  mass  derived  from  the  right  axillary
region which was extending to the anterior
and  posterior  thoracic  wall  with  fluid-filled
cavities about 12 cm in size. There was no
evidence  of  intrathorasic  or  intraabdominal
extension  of  mass.  Cordocentesis  was  per-
formed and karyotype examination was nor-
mal 46 XY. The fetal demise was found after
the first visit. The patient was delivered vagi-
nally after labor induction with oxytocin infu-
sion. The fetal autopsy confirmed the diagno-
sis of CH.
The fetal CH carries high risk of aneuploidy
and  fetal  malformations.  Patients  that  have
been diagnosed with CH in antenatal follow-
ups  should  be  assessed  in  terms  of  other
anomalies. Fetal karyotyping should be done
and the patient should be monitored for fetal
hydrops. The birth should be planned in a mul-
tidisciplinary hospital and as neonatal resusci-
tation could be needed, pediatricians should be
consulted. 
Introduction
Cystic hygroma (CH) is a lymphatic malfor-
mation  occurring  in  different  parts  of  fetal
body, typically in the region of the fetal neck
and    axillary,  abdominal  wall,  mediastinal,
inguinal and retroperitoneal areas.1,2 CH may
result from a complete or incomplete  obstruc-
tion in the lymphatics that prevents communi-
cation  with  the  venous  system  and  causes
cysts.3 The hygroma describes an endothelial-
lined  mass  consisting  of  small  to-  medium-
sized  lumina  containing  lymphatic  fluid,
together with a mixture of loose collagen tis-
sue, adipose tissue and, occasionally, vascular
tissue. The cysts may be unilocular, but more
often  the  structure  contains  multiple  cysts
infiltrating  the  surrounding  structures  and
distorting the local anatomy.4 The lack of lym-
phatic drainage leads to an increased volume
of flow in the venous system, resulting in large
veins.5 The  septated  CH  may  result  from  a
complete  obstruction  in  the  lymphatic  sacs
that prevents communication with the venous
system and causes lymph fluid to accumulate
and dissect into tissues, thus creating large
multilocular cysts. Nonseptated CH may result
from a temporary accumulation of lymph fluid
due  to  incomplete  obstructions  of  lymphatic
drai  nage.6,7 Increased lymphatic pressure may
sometimes overcome the incomplete obstruc-
tions, thus explaining the higher spontaneous
resolution rate reported with nonseptated CH.6-8
CH  has  been  associated  with  fetal  aneu-
ploidy,  hydrops  fetalis,  structural  malforma-
tions and intrauterin fetal death.9-11 In particu-
lar they may be associated with Turner syn-
drome, Noonan syndrome, Trisomies, cardiac
anomalies and fetal hydrops.12Two distinct cat-
egories of fetal CH have been described: those
diagnosed in later pregnancy, which tend to be
isolated lymphangiomas, and those diagnosed
in early pregnancy, which are commonly asso-
ciated  with  other  malformations.13,14 Retro  -
spective  case  series  describing  the  prenatal
diagnosis of this condition suggest that those
diagnosed early in pregnancy are associated
with a poor prognosis.8,13,14  When CH appears
septated,  the  prognosis  is  considered  even
worse than the nonseptated form.8,15 Axillary
CH was rarely reported and determined often
in midgestation.16,17 The purpose of this study
was  to  evaluate  karyotypic,  ultrasonographic
and prognostic factors of CH diagnosed during
pregnancy and to describe an axillary localized
CH case.
Case Report 
A  24-years-old  woman,  gravida  1,  para  1,
admitted to our antenatal clinic for gestational
follow-up.  The patient didn’t take any antena-
tal  care  until  admission  to  our  clinic.  Her
socio  economic  status  was  not  good.    The
woman  didn’t  use  folic  acid  drugs  neither
before the pregnancy nor during the pregnan-
cy.  She was nonsmoker and nondrinker. There
was no systemic illness and operation in her
past medical history.  Patient’s vital signs, rou-
tine blood and urine tests were found normal.
Ultrasonographic examination determined 28
weeks of gestation, singleton, alive fetus who
had  a  mass  derived  from  the  right  axillary
region  which  was  extending  to  the  anterior
and posterior thoracic wall with fluid-filled cav-
ities about 12 cm in size (Figure 1). Fetal bio-
metry was appropriate for gestational age, pla-
centa  and  amniotic  fluid  were  normal.  No
other  fetal  anomalies  were  identified.  Color
velocity  imaging  demonstrated  no  flow
through the mass. The diagnosis of axillotho-
racic CH was corrected by magnetic resonance
imaging (MRI) examination (Figure 2). There
was no evidence of intrathorasic or intraab-
dominal extension of mass. Fetal thorax and
abdomen were found normal in MRI examina-
tion. The cordocentesis was performed after
the  patient’s  informed  consent  was  taken.
Karyotype  examination  was  normal  46  XY.
Patient was followed up as outpatient by the
high risk pregnancy department. The patient
admitted  to  antenatal  clinic  3  weeks  later
again because of the lack of fetal movements.
In  ultrasonographic  evaluation,  fetal  demise
was found. The mass was seen as the same
size,  and  there  wasn’t  any  sign  of  hydrops
fetalis , the amniotic fluid was found normal.
The  patient  delivered  vaginally  after  labor
induction with oxytocin infusion. Multiple cord
entanglements were found around fetal neck.
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During the delivery, fetal or cystic damage was
not happened. In postnatal examination a mul-
ticystic, transluminating mass was seen which
measured 15 cm was in maximum diameter.
The mass was extending from axilla to anteri-
or and posterior thoracic wall. There was no
fetal anomaly in fetal macroscopic examina-
tion  except  axillothorasic  cystic  mass  and
there was no apparent invasion of the mass
into chest cavity and  no parenchymal lung dis-
ease. As a result of the fetal autopsy and patho-
logical  findings,  it  was  diagnosed  as  CH.
Histological examination demonstrated cystic
lymphangioma  with  dilated  communicating
lymphatic vessels lined by normal epithelium
and cystic areas with rare aggregates of lym-
phocytes (Figure 3). Additional fetal anomaly
wasn’t detected. 
Discussion 
Fetal  CH  is  a  congenital  malformation  in
which  distended  fluid-filled  spaces  develop,
typically in the region of the fetal neck. Cystic
hygromas  are  slow-growing  benign  tumours
resulting from a developmental anomaly of the
lymphatic  system.18 The  lymphatic  system
begins to develop in 6 weeks, and then com-
bines  with  venous  system.  The  inability  of
combination between venous system and lym-
phatic system results in CH.18,19
CH  has  been  associated  with  fetal  aneu-
ploidy,  hydrops  fetalis,  structural  malforma-
tions and intrauterin fetal death.9-11It is report-
ed to occur between 1 in 6000 and 1 in 16,000
live births but it is estimated to be much more
than this proportion as we take into account
the abortions (1/875).18,19 CH can occur any-
where in the body, but 75% involve the posteri-
or  neck,  20%  the  axilla  and  1%  the  medi-
astinum,  groin  and  retroperitoneum.19,20 In
particular they may be associated with Turner
syndrome, Noonan syndrome, Trisomies, car-
diac anomalies, fetal hydrops.12 If this inability
is  severe,  the  progressive  peripheral  lymph
edema  and  hydrops  develops  and  results  in
early  fetal  loss.19 Two  distinct  categories  of
fetal CH have been described: those diagnosed
in later pregnancy, which tend to be isolated
lymphangiomas, and those diagnosed in early
pregnancy,  which  are  commonly  associated
with  other  malformations.13,14 Retro  spective
case series describing the prenatal diagnosis
of this condition suggest that those diagnosed
early in pregnancy are associated with a poor
prognosis.8,13,14 When CH appears septated, the
prognosis is considered even worse than the
nonseptated form.8,15The CH in later gestation,
which likely represents a lymphangioma that
is  not  associated  with  either  aneuploidy  or
other fetal malformations, and can be expected
to yield a good prognosis.13,14 CH incidence is
equal in both sexes, but the inguinal CH is 5
times more common in men.21
A total of 38,167 patients were enrolled at 15
study centers, and a total of 134 cases of CH
were  diagnosed  in  this  population.  Chromo  -
somal abnormality was diagnosed in 67 of 132
cases (51%) of CH.22 18 cases having cystic CH
were detected, 8 cases (44.4%) were found to
have a 45, X karyotype, 3 cases were found to
be mosaic Turner syndrome (16.7%), 5 cases
(27.7%) had normal karyotype, 1 case (5.6%)
trisomy  13,  and  1  case  (5.6%)  trisomy  21.23
Fifty-seven  cases of CH among 8155 screen-
ings (0.7%). 35 of the cases (61.4%) were non-
septated and 22 of the cases (38.6%) were sep-
tated  CH.  Chromosomal  abnormalities  were
found in 23 of the cases (40.3%). The most
common abnormality in nonseptated CH was
trisomy 21 (8 cases, 25%) and in septated CH
was Turner syndrome (4 cases, 21.1%). The
most common associated structural malforma-
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Figure 1. Ultrasonography showing a large
multiseptate mass in the right axilla and  a
Doppler  scaning  no  vascularity  in  the
mass.
Figure  2.  Antenatal T2  weighted  MR  images  of  multioculer  giant  hiperintens  cystic
higroma (arrow) which arise from right arm, axilla, pectoral region and right thorax. (A)
A coronal oblique section which includes bilateral upper extremity and low extremity, (B)
a parasagittal cross section at the level of right arm and leg, (C) an axial image at the level
of axilla.
Figure 3. Histological examination demonstrated lymphatic endothelium lining cyst wall
at the surface and cystic dilatated lymphatic vessels at the subcutan tissue.[page 124] [Rare Tumors 2011; 3:e39]
tion  was  cardiac  abnormalities  (in  7  cases,
20%)  in  nonseptated  CH  cases  and  nonim-
mune hydrops (in 12 cases, 54.5%) in septated
CH cases.24
Sixty-four cases of CH in 8524 patients were
detected (0.75%). Thirty-nine (60.9%) were of
non-septated and 25 (39.1%) were of septated
CH. Chromosomal abnormalities were present
in 25 (39.1%). The most common abnormality
in non-septated CH was trisomy 21 (27.8%),
and that in septated CH was Turner syndrome
(23.8%). Nine of the infants were live-born and
were  subsequently  followed  up  but,  two  had
cardiac pathology and died after cardiac opera-
tion, two others were diagnosed with axillary
CH,  had  an  excellent  prognosis.  Only  three
cases had, at birth and in the follow-up period,
no complications.It was indicated that the CH
is highly correlated with adverse perinatal out-
come.25
Previously, a large multicenter study report-
ed  that  there  were  134  cases  of  CH  among
38,167 screened patients (1 in 285). Chromo  -
somal  abnormalities  were  diagnosed  in  67
(51%), including 25 trisomy-21, 19 Turner syn-
drome,  13  trisomy-18,  and  10  others.  Major
structural fetal malformations (primarily car-
diac and skeletal) were diagnosed in 22 of the
remaining  65  cases  (34%).  Overall,  survival
with normal pediatric outcome was confirmed
in 17% of cases (22 of 132). The CH has 5-fold,
12-fold, and 6-fold increased risk of aneuploidy,
cardiac  malformation,  and  perinatal  death,
respectively.26 Chromosomal  abnormalities
were found  52.7% (38/72) in 72 fetuses who
had detected CH at first trimester screening
and, including 14 cases (36.8%) of Down syn-
drome.  A  total  of  34  chromosomally  normal
pregnancies ended with 18 live births (52.9%),
with no visible serious structural abnormali-
ties. The 18 live-born infants were followed up
for 17-98 months. Sixteen infants developed
normally,  while  1  developed  Noonan’s  syn-
drome and 1 had a urinary tract abnormality.
These data suggest that the prognosis of fetal
CH detected during the first trimester is poor.27
Axillary  CH  is  rarely  reported  and  deter-
mined often by sonographically in midgesta-
tion.16,17 Axillothoracic CH may be diagnosed
during routine antenatal ultrasound follow-up.
These  are  the  masses  simple  or  multicystic
structured,  hypoechogenic,  with  thin  septat,
and  they  may  contain  solid  components.28,29
Generally, the vascular flow isn’t seen in the
Doppler  ultrasound  examination.  MRI  is
important in determining the characteristics
of the tissue and tumor extent.30 Axillary lym-
phangiomas account for approximately 10% of
all lymphangiomas. Very few have been report-
ed as diagnosed prenatally.6 A few cases have
been reported of shoulder dystocia caused by
axillary lymphangioma diagnosed after deliv-
ery.7 McCoy et al. reported, a child with bilater-
al axillary CH that were prenatally diagnosed at
18th week of gestation.31
Traditionally,  ultrasonography  has  been
used as the primary screening method for pre-
natal diagnosis, especially in cervical lesions.
CT  is  avoided  because  of  issues  relating  to
radiation exposure to mother and foetus. MRI
may  play  a  role  in  prenatal  imaging,  as
amongst other things it provides early compre-
hensive information about both the anatomy
and the extension of the tumour.32
Obstetric prognosis in CH cases depends on
the volume and localization of the mass. Fetal
prognosis is determined by the degree of chro-
mosomal anomalies and hydrops.33 With serial
ultrasound follow-up, the size of the mass is
followed and for the masses that may develop
dystocia so section is recommended. In isolat-
ed small masses, the standard obstetric treat-
ment is recommended. In larger masses that
may prevent the birth, intrauterine cyst aspira-
tion may be carried out and this process also
can be carried out for intrauterine diagnosis.28
Generally, CH has no risk of recurrence in sub-
sequent  pregnancies.  But  recurrent  familial
CH  cases  have  been  reported  in  the  litera-
ture.34 In  prenatal  differential  diagnosis  of
axillothoracic CH, simple cysts, hemangiomas,
bran  chial  cleft  cysts,  hemongiolymphan-
giomas, lymphocele, teratomas, hemongioen-
dotheliomas,    ectopia  cortis,  amniotic  band
syndrome, Klippel-Trauray syndrome should be
considered.35
These  tumors  do  not  show  spontaneous
recovery after childbirth, they are treated sur-
gically with excision. Infiltrative and extensive
masses are difficult to be extracted surgically.
If total surgical excision isn’t carried out, the
recurrence  may  be  seen.  Other  treatment
options  include  injections  of  the  sclerosing
agent, CO2 laser therapy and radiotherapy.12,35
When the cyst is aspirated with an injector, it
may lead to the rapid fluid accumulation and it
isn’t suggested as it may cause infection.12 For
the treatment of CH, the new modality is the
use of sclerosing agents.36 For the first time in
1986,  by  Ogita  et  al. proposed  treatment  of
intralesional injection of OK-432.37 OK432 is a
sclerosing agents obtained from derivative of
low virulence Streptococcus pyogenes.38OK432
activates white blood cells; increases cytokines
(such  as  TNF)  improves  endothelial  perme-
ability  and  improves  the  lymphatic  drainage
from the cystic area.39 OK423 has been accept-
ed  as  safe  and  effective  alternative  treat-
ment.39 It may be used as a primary treatment
and after recurrent CH or partial surgical treat-
ment. The success of the treatment of multi-
cystic CH is low but it is better in simple cysts.
It  has  no  effect  on  post-surgical  treatment
after OK432 treatment. As it doesn’t cause the
formation of fibrosis in surgical excision area,
it does not affect the surgery after the injec-
tion.35 Recently,  intrauterine  OK432  treat-
ments have been reported.36
The fetal CH carries high risk of aneuploidy
and  fetal  malformations.  Patients  that  have
been diagnosed with CH in antenatal follow-
ups  should  be  assessed  in  terms  of  other
anomalies,  fetal  karyotyping  should  be  done
and the patient should be monitored for fetal
hydrops. The cyst size and structure, septat or
nonseptat, localization and invasion of cyst are
important  prognostic  factors.  The  axillary
localization  and  spontaneous  resolution  of
septa  are  good  prognostic  factors.  The  birth
should be planned in a multidisciplinary hospi-
tal  and  as  neonatal  resuscitation  could  be
needed, pediatricians should be consulted. 
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